Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets identify genetic cause of fatal condition in Thoroughbreds
EFIH is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals.
Study of affected foals reveals a mutation in the RAPGEF5 gene.

A genetic cause of equine familial isolated hypoparathyroidism (EFIH) in Thoroughbreds has been identified by researchers at the UC Davis School of Veterinary Medicine.

Researchers say their finding, reported in PloS Genetics, marks the first genetic variant for hypoparathyroidism identified in any domestic animal species. It is also the first widely available genetic test for Thoroughbreds.

“For Thoroughbred owners and breeders, the loss of a foal has tremendous economic and emotional impacts,” says first author Victor Rivas. “It is important to promote safe and strategic breeding habits by actively breeding horses genetically screened not only for EFIH but for other diseases that may impact quality of life.”

EFIH is is an invariably fatal condition that causes involuntary contraction of muscles and seizures in Thoroughbred foals. Foals with the disease typically have low levels of parathyroid - a hormone that controls calcium levels - and often die or are euthanised owing to poor prognosis.

In the study, researchers identified an autosomal recessive mode of inheritance and performed whole-genome sequencing of two affected foals. They found that a mutation in the rap guanine nucleotide exchange factor 5 (RAPGEF5) gene was present in two copies in both foals.

The team further analysed the variant and demonstrated loss-of-function of the RAPGEF5 protein leading to aberrant development. Their study concludes that RAPGEF5 could play a key role in the derivation of the parathyroid gland during development.

“The next steps are to assess the allele frequency in a large population of randomly selected Thoroughbreds,” explained study lead Dr Carrie Finno. “Additionally, we have discussed collaborating with Dr Nathan Slovis at Hagyard Equine Medical Institute in Kentucky to test for the variant in cases of ‘sudden death’ in Thoroughbred foals.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.